000048279 000__ 01549cam\a22004215i\4500
000048279 001__ 48279
000048279 003__ SzGeWIPO
000048279 005__ 20240708150401.0
000048279 006__ m\\\\eo\\d\\\\\\\\
000048279 007__ cr bn |||m|||a
000048279 008__ 230612s2023    nyu|||||o|||||000|0 eng|d
000048279 035__ $$a(OCoLC)1393694778
000048279 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO
000048279 041__ $$aeng
000048279 24502 $$aA milestone decision on the patentability of second medical use claims.
000048279 264_1 $$a[New York, NY] :$$bThomson Reuters,$$c2023
000048279 300__ $$a1 online resource
000048279 336__ $$atext$$2rdacontent
000048279 337__ $$acomputer$$2rdamedia
000048279 338__ $$aonline resource$$bcr$$2rdacarrier
000048279 4901_ $$aEuropean Intellectual Property Review,$$x0142-0461 ;$$vVolume 45, Issue 2
000048279 542__ $$fhttps://1.next.westlaw.com/Copyright
000048279 588__ $$aCrossref
000048279 590__ $$aPublished online: 2023
000048279 650_0 $$aIntellectual property.
000048279 650_0 $$aPatents$$zTurkey.
000048279 650_0 $$aPharmaceuticals.
000048279 650_0 $$aPatents.
000048279 650_0 $$aEconomic development projects$$xDirectories.
000048279 7001_ $$aErciyas, Selin Sinem,$$eauthor.
000048279 7001_ $$aYatkın, Aysel Korkmaz,$$eauthor.
000048279 7001_ $$aEryaşar, Aysu,$$eauthor.
000048279 7731_ $$tEuropean Intellectual Property Review
000048279 7731_ $$wEIPR
000048279 830_0 $$aEuropean Intellectual Property Review,$$x0142-0461 ;$$vE.I.P.R. 2023, 45(2), 57-58
000048279 85641 $$uhttps://www.westlaw.com/Document/IB7D7EE7096CC11ED91BDAB39130A57B8/View/FullText.html?transitionType=Default&contextData=(sc.Default)&VR=3.0&RS=cblt1.0&sp=wlnintell-000$$yonline version
000048279 904__ $$aJournal article
000048279 980__ $$aEIPR